Neurology & Autoimmune Research
Multiple Sclerosis Clinical Research
Multiple Sclerosis (MS) is a chronic neurological disease that affects the central nervous system and impacts millions worldwide. CenExel partners with sponsors to advance innovative therapies through specialized clinical research focused on improving patient outcomes, slowing disease progression, and enhancing quality of life.
Studies Conducted
0
+
Trial Participants
0
+
Active Sites
0
+
Overview
Advancing Multiple Sclerosis Research
CenExel supports comprehensive Multiple Sclerosis clinical trials through experienced investigators, advanced operational capabilities, and access to diverse patient populations. Our research teams are committed to accelerating treatment innovation across relapsing-remitting MS, progressive MS, and related neurological conditions.
Conditions Covered
Multiple Sclerosis Conditions We Research
Our MS research programs support a broad range of neurological and autoimmune conditions.
- Relapsing-Remitting MS (RRMS)
- Secondary Progressive MS (SPMS)
- Primary Progressive MS (PPMS)
- Clinically Isolated Syndrome (CIS)
- Neuromyelitis Optica (NMO)
- Cognitive Impairment in MS
- MS-Related Fatigue
- Neuropathic Pain
Our Approach
Why Sponsors Choose CenExel for MS Research
CenExel delivers specialized neurological research expertise, efficient enrollment strategies, and operational excellence for Multiple Sclerosis clinical studies.
01
Expert Neurology Teams
Our experienced investigators and coordinators specialize in neurological and autoimmune disorders.
02
Biomarker & Imaging Support
Advanced imaging capabilities and biomarker strategies help improve study precision and outcomes.
03
Diverse Patient Access
Our nationwide site network enables access to diverse MS patient populations.
04
End-to-End Trial Support
From first-in-human studies to Phase IV programs, CenExel provides full clinical trial support.
Phase Coverage
Supported MS Trial Phases
CenExel supports early and late-phase neurological research programs across Multiple Sclerosis and autoimmune disorders.
Active across all phases
- Phase I
- Phase II
- Phase III
- Phase IV
Our research infrastructure supports biomarker-driven studies, imaging-based endpoints, and long-term patient follow-up strategies for MS clinical development.
Multiple Sclerosis Task Force
CenExel supports a nationwide network of neurology-focused research sites dedicated to Multiple Sclerosis and autoimmune neurological disorders across adult and senior patient populations.
Active Sites
18 Sites
CenExel Phoenix
CenExel Anaheim
CenExel Atlanta
CenExel Marlton
CenExel Gaithersburg
